Company Overview:
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, vaccination for COVID-19 and Influenza (flu) is mandatory for all MSK staff who do not work 100% remotely (including new hires ). Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical, religious, or fully remote exemption. Requests for exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
Job Description:
The Gastrointestinal Oncology Service in Division of Solid Tumor Oncology the Department of Medicine is seeking a full-time early career investigator in Gastroesophageal Cancer Translational Research. This physician-scientist, appointed as Debbie’s Dream Foundation Gastric Cancer Investigator, would focus exclusively on patient care, research, and education for esophageal and gastric cancers. This faculty would have one year of protected research time focused on biomarker development, laboratory, and translational research in gastroesophageal cancer with Dr. Yelena Janjigian's, Chief of the Gastrointestinal Oncology Service, mentorship to advance translational studies in gastroesophageal cancer.
Why Join Us?
- Cutting-Edge Research: Contribute to highly productive research programs leading over 25 clinical trials, including major contributions to FDA approvals of groundbreaking treatments like nivolumab, pembrolizumab/trastuzumab, and trastuzumab deruxtecan for gastroesophageal cancers.
- Mentorship: Benefit from the mentorship of Dr. Janjigian, an experienced leader in the field, and collaborate with a diverse team of experts dedicated to advancing cancer care.
- Impactful Work: Your research efforts will directly impact patient outcomes, driving innovation and progress in the fight against gastroesophageal cancers.
Requirements Include:
- MD and/or PhD in relevant field (e.g., oncology, translational medicine, molecular biology)
- Strong passion for translational research and advancing cancer therapeutics
- Excellent communication and collaboration skills
- Ability to work independently and as part of a multidisciplinary team
Location: New York, New York
Salary Range: $70,000-$110,000
Application Process: Interested candidates should submit their CV, cover letter outlining research interests and career goals, and contact information for three references to and .
Closing:
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.
